Use of anticholinergic bronchodilation in children

The American Journal of Medicine
B K Rubin, G M Albers

Abstract

Ipratropium bromide is a quaternary ammonium anticholinergic bronchodilator with minimal systemic absorption across the blood-airway barrier. Ipratropium bromide has become primary therapy for the treatment of adults with chronic bronchitis, but its use in children has been limited. Ipratropium bromide can be safely used in the management of acute bronchiolitis, recognizing that most infants do not appear to respond to any bronchodilator medication. When used with a beta-agonist bronchodilator for the therapy of acute childhood asthma, ipratropium bromide appears to provide bronchodilation beyond that achieved by either agent used alone. There are insufficient published data to determine the appropriate use if ipratropium bromide in infants with bronchopulmonary dysplasia, although many of those symptomatic after the age of 6 months seem to benefit from either ipratropium bromide or beta-agonists. As ipratropium bromide has no intrinsic anti-inflammatory properties, its role in the chronic therapy of asthma and related disorders is still unclear.

References

Mar 1, 1992·Archives of Disease in Childhood·E E WangH Maj
Oct 1, 1991·European Journal of Pediatrics·B Yuksel, A Greenough
Nov 1, 1990·The American Review of Respiratory Disease·K L BrundageJ T Fisher
Apr 1, 1989·Australian Paediatric Journal·R L HenryR Abramson
Nov 14, 1986·The American Journal of Medicine·A Wanner
Apr 1, 1987·Archives of Disease in Childhood·A PrendivilleM Silverman
Jun 1, 1987·Australian Paediatric Journal·J SeidenbergP D Phelan
Apr 1, 1983·Archives of Disease in Childhood·G M StokesM C Elphick
Jan 1, 1984·Archives of Disease in Childhood·R L HenryG M Stokes
Oct 1, 1981·Australian and New Zealand Journal of Medicine·C R JenkinsG E Marlin
Jan 1, 1982·Thorax·N P Mann, E J Hiller
Apr 1, 1981·The Journal of Pediatrics·D GurwitzH Levison

❮ Previous
Next ❯

Citations

Jun 18, 2002·Chest·Uma R KotagalMark S Kirschbaum
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Federico Martinón-Torres
Feb 1, 1997·Acta Paediatrica Japonica; Overseas Edition·R CengizlierA Tuncer
Aug 15, 2003·The Cochrane Database of Systematic Reviews·N J McDonald, A I Bara
Jan 5, 2002·Indian Journal of Pediatrics·H YukselA Onag
Mar 3, 2005·Medicine and Science in Sports and Exercise·Bruno H KnöpfliClaudio G S Araújo
Feb 24, 2005·Treatments in Respiratory Medicine·Kuender D Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.